IHZ

Serial Number 86739853
606

Registration Progress

Application Filed
Aug 27, 2015
Under Examination
May 24, 2016
Approved for Publication
Mar 29, 2016
Published for Opposition
Mar 29, 2016
Registered

Trademark Image

IHZ

Basic Information

Serial Number
86739853
Filing Date
August 27, 2015
Published for Opposition
March 29, 2016
Abandonment Date
June 24, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 24, 2019
Classes
001 005 042

Rights Holder

CytomX Therapeutics, Inc.

03
Address
343 Oyster Point Blvd, Suite 100
South San Francisco, CA 94080

Ownership History

CytomX Therapeutics, Inc.

Original Applicant
03
South San Francisco, CA

CytomX Therapeutics, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Janet L. Cullum

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

39 events
Date Code Type Description Documents
Jun 24, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 24, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 24, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 23, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 23, 2018 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 16, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 16, 2018 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 20, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 18, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 18, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 18, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 21, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 19, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 19, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 19, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 15, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 13, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 13, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 13, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 18, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 14, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 14, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 14, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 24, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 29, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 29, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 9, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 23, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Feb 16, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 11, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 11, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 10, 2016 ALIE A ASSIGNED TO LIE Loading...
Feb 4, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 18, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 18, 2015 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 18, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 12, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 1, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 31, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Assays and reagents for use in scientific, laboratory and research purposes; biochemical test kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding, for scientific, laboratory and research purposes; assay kits comprised of assays and for non-medical purposes for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Assays and reagents for use in medical, diagnostic and therapeutic purposes; biochemical test kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding, for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, and antibody binding, for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, and antibody binding, for use in identifying candidate patient populations for specific therapeutic treatments
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Providing scientific research information and analysis relating to biochemicals, proteolytic activation, antibody binding, therapeutic treatments, patient recovery, and the identification of candidate patients for specific therapeutic treatments; testing, research, design and development services in the field of biochemicals for scientific purposes; research, design and development of assays for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
001 005 042